Novo Nordisk the company that makes Ozempic and Wegovy has made clear it "does not directly or indirectly provide or sell bulk semaglutide to compounding pharmacies," and the FDA in January said it received reports of some compounders using salt forms of semaglutide, which is not the same active ingredient as the base form of semaglutide used in brand-name weight loss drugs
McMurray JJV, Solomon SD, Inzucchi SE, et al
Focus during this month should be on establishing healthy eating patterns and staying hydrated
FDA Approves Novo Nordisks Wegovy Pill, the First and Only Oral GLP-1 for Weight Loss in Adults
Multi-targeted protection of acetaminophen-induced hepatotoxicity in mice by tannic acid
Karsdal MA, Byrjalsen I, Azria M, et al